Double-acting target pharmaceutical compositions for the treatment of cancer sufferers comprising at least a pharmaceutically effective amount of saikosaponin compound and dichloroacetate salt
A pharmaceutical composition for preparing a medicament for the treatment of an individual cancer, comprising at least a pharmaceutically effective amount of saikosaponin compound and dichloroacetate salt wherein the ratio (SSD: DCA) of the total content of the saikosaponin compound (SSD) relative to the total content of dichloroacetate (DCA) is in the range of about 1: 1 to 1: 25000. Preferably, the pharmaceutical composition may further comprise a cancer reversal signal substance and at least one selected from the group consisting of other pharmaceutically acceptable carriers, carriers, diluents, and excipients the proportion of respective ingredients in the pharmaceutical composition is adjusted according to the type of cancer. The pharmaceutical composition may preferably further comprise: vitamin A, vitamin B, thiamine, vitamin B1, vitamin B2, vitamin B6, vitamin Bl2, vitamin C, vitamin D, Vitamin E, Vitamin K, lipoicacid, curcumin, and mixtures thereof.一種醫藥組成物,其係用於製備治療個體癌症用之藥物,該醫藥組成物至少包含藥學上有效量之柴胡皂苷化合物、及二氯醋酸鹽;其中該柴胡皂苷化合物的總含量(SSD)相對於二氯醋酸鹽的總含量(DCA)的比率(SSD:DCA)為在約1:1至1:25000之範圍。
